Is Artiva Biotherapeutics, Inc. (ARTV) a Buy, Sell, or Hold?
Artiva Biotherapeutics, Inc.
NASDAQ:ARTV
$9.35 USD
$0.42 (4.7%)
- Volume
- 432.58K
- Average Volume
- 618.56K
- Market Capitalization
- $231.11M
- P/E Ratio
- -2.63
- Dividend Yield
- 0.00%
- Price Target
- $37.50
- Year High
- $14.53
- Year Low
- $2.07
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $8.16
Analyst Rating
Sell
2 Rating Score
UPSIDE/DOWNSIDE
-75.1% DOWNSIDE
$37.50 Price Target
UPSIDE/DOWNSIDE HIGH
-76.6% DOWNSIDE
$40.00 Price Target High
UPSIDE/DOWNSIDE LOW
-73.3% DOWNSIDE
$35.00 Price Target Low
INSIDER TRADING
Shares
$- Last Quarter
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Wedbush | David Nierengarten | $40 | $11.15 | 2026-05-11 07:47 AM | 258.7% |
| Wedbush | David Nierengarten | $18 | $11.22 | 2024-08-13 03:39 AM | 60.4% |
| Needham | Gil Blum | $23 | $11.22 | 2024-08-13 02:51 AM | 105.0% |